Association of laboratory parameters and genetic polymorphisms with ischemic stroke in Chinese Han population

Wang,Jiayong; Sun,Zujun; Yang,Yibao; Wu,Junlu; Quan,Wenqiang; Chen,Xingcai; Ni,Peihua; Li,Dong

doi:10.3892/etm.2021.9921

Association of laboratory parameters and genetic polymorphisms with ischemic stroke in Chinese Han population

Authors:
- Jiayong Wang
- Zujun Sun
- Yibao Yang
- Junlu Wu
- Wenqiang Quan
- Xingcai Chen
- Peihua Ni
- Dong Li
View Affiliations

Affiliations: Faculty of Medical Laboratory Science, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200020, P.R. China, Department of Clinical Laboratory, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai 200065, P.R. China, Department of Human Anatomy, Guangxi Medical University, Nanning, Guangxi 530021, P.R. China
Published online on: March 16, 2021 https://doi.org/10.3892/etm.2021.9921
Article Number: 490
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Numerous genetic polymorphisms and clinical laboratory parameters are associated with ischemic stroke (IS). However, the results of such studies have frequently been inconsistent. The aim of the present study was to evaluate associations between clinical laboratory parameters with genetic polymorphisms that influence the risk of IS in a Chinese Han population. Clinical laboratory parameters were measured by an automatic biochemical analyzer. Genotype and allele frequencies of the polymorphisms angiotensin‑converting enzyme (ACE) D/I, methylene tetrahydrofolate reductase (MTHFR) C677T and β‑fibrinogen (β‑Fg) A/G, 455/148T/C were characterized by restriction fragment length polymorphism‑PCR. Furthermore, the gene polymorphisms plasminogen activator inhibitor (PAI)‑1-4G/5G and apolipoprotein E (ApoE) ε2,3,4 were characterized by allele‑specific PCR. The associations of genotype and allele frequencies of the six risk genes in different groups with clinical laboratory parameters were analyzed by chi‑square tests. The distribution maps of the polymorphisms of the six genes and clinical laboratory parameters were compared between a control group of 336 healthy individuals and 762 patients with IS. Certain laboratory parameters were associated with ACE I/D, β‑Fg‑455 A/G and PAI‑1 4G/5G. The D allele of ACE I/D was associated with high levels of total cholesterol and low‑density lipoprotein cholesterol (LDL‑C). Furthermore, high levels of fasting blood glucose, triglyceride and LDL‑C were risk factors for IS. There were significant differences in the genotype frequencies of ACE I/D, β‑Fg‑455 A/G and β‑Fg‑148 T/C between the IS and the control group. In conclusion, clinical laboratory parameters were associated with the risk of polymorphisms of IS‑related genes. The present results support the determination of a range of control values of clinical laboratory parameters for common genotypes in patients with diabetes and hyperlipidemia as a strategy for the early prevention of IS.

View Figures

View References

1	Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL and Parag V: Worldwide stroke incidence and early case fatality reported in 56 population-based studies: A systematic review. Lancet Neurol. 8:355–369. 2009.PubMed/NCBI View Article : Google Scholar
2	Sacco RL, Kasner SE, Broderik JP, Caplan LR, Connors JJ, Culebras A, Elkind MS, George MG, Hamdan AD, Higashida RT, et al: An updated definition of stroke for the 21st century: A statement for healthcare professionals from the American heart association/American stroke association. Stroke. 44:2064–2089. 2013.PubMed/NCBI View Article : Google Scholar
3	Liu L, Wang D, Wong KS and Wang Y: Stroke and stroke care in China: Huge burden, significant workload, and a national priority. Stroke. 42:3651–3654. 2011.PubMed/NCBI View Article : Google Scholar
4	Feigin VL, Roth GA, Naghavi M, Parmar P, Krishnamurthi R, Chugh S, Mensah GA, Norrving B, Shiue I, Ng M, et al: Global burden of stroke and risk factors in 188 countries, during 1990-2013: A systematic analysis for the global burden of disease study 2013. Lancet Neurol. 15:913–924. 2016.PubMed/NCBI View Article : Google Scholar
5	Liang C, Ni G, Ma J, Liu H, Mao Z, Sun H and Zhang X: Impact of tag single nucleotide polymorphisms (SNPs) in CCL11 gene on risk of subtypes of ischemic stroke in Xinjiang Han populations. Med Sci Monit. 23:4291–4298. 2017.PubMed/NCBI View Article : Google Scholar
6	Bersano A, Ballabio E, Bresolin N and Candelise L: Genetic polymorphisms for the study of multifactorial stroke. Hum Mutat. 29:776–795. 2008.PubMed/NCBI View Article : Google Scholar
7	Huen K, Yousefi P, Street K, Eskenazi B and Holland N: PON1 as a model for integration of genetic, epigenetic, and expression data on candidate susceptibility genes. Environ Epigenet. 1(dvv003)2015.PubMed/NCBI View Article : Google Scholar
8	Zhang Z, Xu G, Liu D, Fan X, Zhu W and Liu X: Angiotensin-converting enzyme insertion/deletion polymorphism contributes to ischemic stroke risk: A meta-analysis of 50 case-control studies. PLoS One. 7(e46495)2012.PubMed/NCBI View Article : Google Scholar
9	Tuncer N, Tuglular S, Kılıç G, Sazci A, Us O and Kara I: Evaluation of the angiotensin-converting enzyme insertion/deletion polymorphism and the risk of ischaemic stroke. J Cli Neurosci. 13:224–227. 2006.PubMed/NCBI View Article : Google Scholar
10	Pera J, Slowik A, Dziedzic T, Wloch D and Szczudlik A: ACE I/D polymorphism in different etiologies of ischemic stroke. Acta Neurol Scand. 114:320–322. 2006.PubMed/NCBI View Article : Google Scholar
11	Liu J, Sun K, Bai Y, Zhang W, Wang X, Wang Y, Wang H, Chen J, Song X, Xin Y, et al: Association of three-gene interaction among MTHFR, ALOX5AP and NOTCH3 with thrombotic stroke: A multicenter case-control study. Hum Genet. 125:649–656. 2009.PubMed/NCBI View Article : Google Scholar
12	Arina CA, Amir D, Siregar Y and Sembiring RJ: The Role of polymorphism gen methylene tetra hydrofolate reductase (MTHFR) C677T in ischaemic stroke patients with and without hypertension. Open Access Maced J Med Sci. 7:29–32. 2019.PubMed/NCBI View Article : Google Scholar
13	Coen Herak D, Lenicek Krleza J, Radic Antolic M, Horvat I, Djuranovic V, Zrinski Topic R and Zadro R: Association of polymorphisms in coagulation factor genes and enzymes of homocysteine metabolism with arterial ischemic stroke in children. Clin Appl Thromb Hemost. 23:1042–1051. 2017.PubMed/NCBI View Article : Google Scholar
14	Kopyta I, Niemiec P, Balcerzyk A, Emich-Widera E, Pilarska E, Pienczk-Ręcławowicz K, Kaciński M, Wendorff J, Nowak T, Iwanicki T, et al: Fibrinogen alpha and beta gene polymorphisms in pediatric stroke-case-control and family based study. Eur J Paediatr Neurol. 19:176–180. 2015.PubMed/NCBI View Article : Google Scholar
15	Kumar A, Misra S, Kumar P, Sagar R and Prasad K: Association between beta-fibrinogen C148T gene polymorphism and risk of ischemic stroke in a north Indian population: A case-control study. Pulse (Basel). 4:165–171. 2017.PubMed/NCBI View Article : Google Scholar
16	Hu X, Zan X, Xie Z, Li Y, Lin S, Li H and You C: Association between plasminogen activator inhibitor-1 genetic polymorphisms and stroke susceptibility. Mol Neurobiol. 54:328–341. 2017.PubMed/NCBI View Article : Google Scholar
17	Eriksson P, Kallin B, Van't Hooft FM, Båvenholm P and Hamsten A: Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci USA. 92:1851–1855. 1995.PubMed/NCBI View Article : Google Scholar
18	Iacoviello L, Burzotta F, Di Castelnuovo A, Zito F, Marchioli R and Donati MB: The 4G/5G polymorphism of PAI-1 promoter gene and the risk of myocardial infarction: A meta-analysis. Thromb Haemost. 80:1029–1030. 1998.PubMed/NCBI
19	Jood K, Ladenvall P, Tjärnlund-Wolf A, Ladenvall C, Andersson M, Nilsson S, Blomstrand C and Jern C: Fibrinolytic gene polymorphism and ischemic stroke. Stroke. 36:2077–2081. 2005.PubMed/NCBI View Article : Google Scholar
20	Wiklund PG, Nilsson L, Ardnor SN, Eriksson P, Johansson L, Stegmayr B, Hamsten A, Holmberg D and Asplund K: Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of stroke: Replicated findings in two nested case-control studies based on independent cohorts. Stroke. 36:1661–1665. 2005.PubMed/NCBI View Article : Google Scholar
21	Mahley RW and Rall SC Jr: Apolipoprotein E: Far more than a lipid transport protein. Annu Rev Genomics Hum Genet. 1:507–537. 2000.PubMed/NCBI View Article : Google Scholar
22	Pezzini A, Grassi M, Del Zotto E, Bazzoli E, Archetti S, Assanelli D, Akkawi NM, Albertini A and Padovani A: Synergistic effect of apolipoprotein E polymorphisms and cigarette smoking on risk of ischemic stroke in young adults. Stroke. 35:438–442. 2004.PubMed/NCBI View Article : Google Scholar
23	Sturgeon JD, Folsom AR, Bray MS, Boerwinkle E and Ballantyne CM: Atherosclerosis Risk in Communities Study Investigators. Apolipoprotein E genotype and incident ischemic stroke: The aherosclerosis rsk in cmmunities sudy. Stroke. 36:2484–2486. 2005.PubMed/NCBI View Article : Google Scholar
24	Chinese Neurology Association. Chinese guidelines for the diagnosis and treatment of acute ischemic stroke in 2014. Chin J Neurol. 48:246–257. 2015.
25	Murray CJ and Lopez AD: Measuring the global burden of disease. N Engl J Med. 369:448–457. 2013.PubMed/NCBI View Article : Google Scholar
26	Beal CC: Gender and stroke symptoms: A review of the current literature. J Neurosci Nurs. 42:80–87. 2010.PubMed/NCBI
27	Fluri F, Schuhmann MK and Kleinschnitz C: Animal models of ischemic stroke and their application in clinical research. Drug Des Devel Ther. 9:3445–3454. 2015.PubMed/NCBI View Article : Google Scholar
28	Li G, Liu Y, Li X, Ning Z, Sun Z, Zhang M, Lu Y, Wu L and Wang L: Association of PAI-1 4G/5G polymorphism with ischemic stroke in Cinese patients with type 2 diabetes mellitus. Genet Test Mol Biomarkers. 22:554–560. 2018.PubMed/NCBI View Article : Google Scholar
29	Zhao LL, Su G, Chen LX, Yan Q, Wang XP, Yuan W, Wang L and Zhang ZC: Apolipoprotein E polymorphisms are associated with ischemic stroke susceptibility in a Northwest China Han population. Biosci Rep. 37(BSR20171088)2017.PubMed/NCBI View Article : Google Scholar
30	Lin CC, Yang CP, Li CI, Liu CS, Chen CC, Lin WY, Hwang KL, Yang SY and Li TC: Visit-to-visit variability of fasting plasma glucose as predictor of ischemic stroke: Competing risk analysis in a national cohort of Taiwan diabetes study. BMC Med. 12(165)2014.PubMed/NCBI View Article : Google Scholar
31	Lee JS, Chang PY, Zhang Y, Kizer JR, Best LG and Howard BV: Triglyceride and HDL-C dyslipidemia and risks of coronary heart disease and ischemic stroke by glycemic dysregulation status: The strong heart study. Diabetes Care. 40:529–537. 2017.PubMed/NCBI View Article : Google Scholar
32	Zhao J, Qin X, Li S and Zeng Z: Association between the ACE I/D polymorphism and risk of ischemic stroke: An updated meta-analysis of 47,026 subjects from 105 case-control studies. J Neuro Sci. 345:37–47. 2014.PubMed/NCBI View Article : Google Scholar
33	Wu G, Cai H, Cai H, Chen Z, Tan L, Qi H and Cai Y: Effect of the-148C/T, 448G/A, and -854G/A polymorphisms of the β-fibrinogen gene on the risk of ischemic stroke in Chinese population. J Stroke Cerebrovasc Dis. 24:1577–1590. 2015.PubMed/NCBI View Article : Google Scholar
34	Anderson RE, Tan WK, Martin HS and Meyer FB: Effects of glucose and PaO2 modulation on cortical intracellular acidosis, NADH redox state, and infarction in the ischemic penumbra. Stroke. 30:160–170. 1999.PubMed/NCBI View Article : Google Scholar
35	Kawai N, Keep RF and Betz AL: Hyperglycemia and the vascular effects of cerebral ischemia. Stroke. 28:149–154. 1997.PubMed/NCBI View Article : Google Scholar
36	Dietrich WD, Alonso O and Busto R: Moderate hyperglycemia worsens acute blood-brain barrier injury after forebrain ischemia in rats. Stroke. 24:111–116. 1993.PubMed/NCBI View Article : Google Scholar
37	Pawelczyk M, Kaczorowska B and Baj Z: The impact of hyperglycemia and hyperlipidemia on plasma P-selectin and platelet markers after ischemic stroke. Arch Med Sci. 13:1049–1056. 2017.PubMed/NCBI View Article : Google Scholar
38	Nomura S, Inami N, Iwasaka T and Liu Y: Platelet activation markers, microparticles and soluble adhesion molecules are elevated in patients with arteriosclerosis obliterans: Therapeutic effects by cilostazol and potentiation by dipyridamole. Platelets. 15:167–172. 2004.PubMed/NCBI View Article : Google Scholar
39	Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, et al: 2018 Guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American heart association/American stroke association. Stroke. 49:e46–e110. 2018.PubMed/NCBI View Article : Google Scholar
40	Li YY: Plasminogen activator inhibitor-1 4G/5G gene polymorphism and coronary artery disease in the Chinese Han population: A meta-analysis. PLoS One. 7(e33511)2012.PubMed/NCBI View Article : Google Scholar
41	Guney AI, Ergec D, Kirac D, Ozturhan H, Caner M, Koc G, Kaspar C, Ulucan K and Agirbasli M: Effects of ACE polymorphisms and other risk factors on the severity of coronary artery disease. Genet Mol Res. 12:6895–6906. 2013.PubMed/NCBI View Article : Google Scholar
42	Suzuki T, Yokota H, Yamazaki T, Kitamura K, Yamaoki K, Nagai R and Yazaki Y: Angiotensin converting enzyme polymorphism is associated with severity of coronary heart disease and serum lipids (total cholesterol and triglycerides levels) in Japanese patients. Coron Artery Dis. 7:371–375. 1996.PubMed/NCBI View Article : Google Scholar
43	Lee YJ and Tsai JC: ACE gene insertion/deletion polymorphism associated with 1998 world health organization definition of metabolic syndrome in Chinese type 2 diabetic patients. Diabetes Care. 25:1002–1008. 2002.PubMed/NCBI View Article : Google Scholar